HER2-Positive Breast Cancer: Update on Breast Cancer International Research Group Trials
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference31 articles.
1. Assessment of methods for tissuebased detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry;Pauletti;J Clin Oncol,2000
2. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer;Slamon;Science,1989
3. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987
4. Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up;Toikkanen;J Clin Oncol,1992
5. Neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer;Andrulis;J Clin Oncol,1998
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molecular and serological biomarkers to predict trastuzumab responsiveness in HER-2 positive breast cancer;Journal of Medicine and Life;2023-11
2. The global patent landscape of HER2-targeted biologics;Nature Biotechnology;2023-06
3. Analysis of the clinicopathological characteristics and prognosis of triple-positive breast cancer and HER2-positive breast cancer—A retrospective study;Frontiers in Oncology;2023-01-12
4. Methodological quality evaluation of systematic reviews or meta-analysis of trastuzumab-based therapy for breast cancer;Medicine;2021-01-29
5. Breast Cancer Therapies and Cardiomyopathy;Medical Clinics of North America;2012-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3